← FDA DRUG APPROVALS

FDA ANDA · ANDA213265

FLUOXETINE

Sponsor: AUROBINDO PHARMA LTD

APPLICATION
ANDA213265
TYPE
ANDA
ORIGINAL APPROVAL
2020-06-10
LATEST ACTION
2026-01-15
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

FLUOXETINE HYDROCHLORIDEPrescription
FLUOXETINE HYDROCHLORIDE EQ 60MG BASE · TABLET · ORAL

Approval history

2026-01-15Manufacturing (CMC) · Supplement 5 · unknownAP
2024-05-02Labeling · Supplement 3 · standardAP
2024-05-02Labeling · Supplement 4 · standardAP
2020-06-10UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →